Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Kolchinsky Peter
Relationship:   Director, 10% Owner
City:   Boston
State:   MA
   
Insider Summary:
  
   
Companies Owned :   21    
Direct Shares   6,648,738    

Indirect Shares

   89,615,900      
Direct Value   $30,628,641    

Indirect Value

   $972,637,484      
Total Shares   96,264,638      
Total Value   $1,003,266,125      


Achillion Pharmaceuticals Inc $29,670,022 Sangamo Biosciences Inc $958,619 Forma Therapeutics Holdings, Inc., $0 Achillion Pharmaceuticals Inc $29,670,022 Sangamo Biosciences Inc $958,619 Forma Therapeutics Holdings, Inc., $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    0    

     Stock price went up :
    1   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   1.0   
   0.0   
     Percentage Gain/Loss :
   14.5%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Aradigm Corp ARDM 10% Owner 2007-03-01 0 2008-01-15 7,681,410    Premium*  
            Curis Inc CRIS 10% Owner 2008-04-15 0 2008-04-15 6,250,564    Premium*  
            Sequenom Inc SQNM 10% Owner 0 2008-06-06 4,617,766    Premium*  
            Biospecifics Technologies Corp BSTC 10% Owner 2008-12-29 0 2009-04-14 825,844    Premium*  
            Lipid Sciences Inc LIPD 10% Owner 2008-03-27 0 2008-03-27 3,705,312    Premium*  
            Achillion Pharmaceuticals Inc ACHN 10% Owner 2013-09-30 4,816,562 2014-09-11 13,000,000    Premium*  
            Sangamo Biosciences Inc SGMO Former 10% Owner 2014-08-01 1,829,426 2013-07-17 0    Premium*  
            Aclaris Therapeutics, Inc. ACRS 10% Owner 2015-10-07 0 2015-10-21 2,314,942    Premium*  
            Ra Pharmaceuticals, Inc. RARX Director, 10% Owner 2016-10-31 0 2020-04-02 0    Premium*  
            Kalvista Pharmaceuticals Inc KALV Director, 10% Owner 2016-11-21 0 2017-10-12 1,441,070    Premium*  
            G1 Therapeutics Inc GTHX Fmr 10% Owner See Foot... 2017-05-22 0 2017-05-22 2,684,244    Premium*  
            Kala Pharmaceuticals, Inc. KALA Director, 10% Owner 2017-07-25 0 2020-03-13 10,874,613    Premium*  
            Wave Life Sciences Ltd. WVE Director, 10% Owner 2017-11-13 0 2019-01-24 7,775,207    Premium*  
            Dicerna Pharmaceuticals Inc DRNA Director 2017-12-18 0 2019-12-02 0    Premium*  
            Eidos Therapeutics, Inc. EIDX 10% Owner 2018-06-22 0 2018-06-22 2,162,671    Premium*  
            Arvinas Holding Company, Llc ARVN Former 10% Owner 2018-10-01 0 2018-10-01 3,138,412    Premium*  
            Synthorx, Inc. THOR Director, 10% Owner 2018-12-11 0 2020-01-23 0    Premium*  
            Satsuma Pharmaceuticals, Inc. STSA Former 10% Owner 2019-09-17 0 2023-06-08 0    Premium*  
            Rhythm Pharmaceuticals, Inc. RYTM 10% Owner 0 2019-10-16 5,422,312    Premium*  
            Forma Therapeutics Holdings, Inc., FMTX Director, 10% Owner 2021-06-17 2,750 2021-06-17 9,011,651    Premium*  
            Solid Biosciences Inc SLDB Director, 10% Owner 0 2020-12-10 8,709,882    Premium*  
* Premium Members only  

Records found :    207         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 9
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
DRNA Dicerna Pharmaceuticals I... Director   –       •      –    2019-12-02 4 S $24.98 $3,427,137 I/I (137,176) 0 0 -
THOR Synthorx, Inc. Director   –       •       •   2020-01-23 4 D $68.00 $661,272,664 I/I (9,724,598) 0 0 -
RARX Ra Pharmaceuticals, Inc. Director   –       •       •   2020-04-02 4 D $48.00 $233,196,480 I/I (4,858,260) 0 0 -
STSA Satsuma Pharmaceuticals, ... Former 10% Owner   –       –      –    2023-06-08 4 D $0.00 $0 I/I (5,914,252) 0 0 -
FMTX Forma Therapeutics Holdin... Director   –       •       •   2021-06-17 4 A $0.00 $0 D/D 2,750 2,750 0 -
DRNA Dicerna Pharmaceuticals I... Director   –       •      –    2019-11-29 4 S $24.22 $3,341,725 I/I (138,000) 137,176 0 -
DRNA Dicerna Pharmaceuticals I... Director   –       •      –    2019-11-27 4 S $24.04 $8,864,765 I/I (368,700) 275,176 0 -
KALV Kalvista Pharmaceuticals ... 10% Owner   –       –       •   2016-11-21 4 A $0.00 $0 I/I 591,070 591,070 0 -
DRNA Dicerna Pharmaceuticals I... Director   –       •      –    2019-11-26 4 S $23.59 $5,653,444 I/I (239,700) 643,876 0 -
BSTC Biospecifics Technologies... 10% Owner   –       –       •   2008-12-22 4 B $18.75 $111,289 I/I 5,500 779,646 1.5 -
BSTC Biospecifics Technologies... 10% Owner   –       –       •   2008-12-23 4 B $20.00 $14,400 I/I 700 780,346 1.5 -
BSTC Biospecifics Technologies... 10% Owner   –       –       •   2008-12-29 4 B $21.33 $212,084 I/I 9,700 790,046 1.5 -
BSTC Biospecifics Technologies... 10% Owner   –       –       •   2008-12-31 4 B $21.40 $116,610 I/I 5,390 795,436 1.5 -
BSTC Biospecifics Technologies... 10% Owner   –       –       •   2009-03-13 4 B $18.25 $100,375 I/I 5,500 805,586 1.5 -
BSTC Biospecifics Technologies... 10% Owner   –       –       •   2009-03-17 4 B $19.94 $106,579 I/I 5,345 810,931 1.5 -
BSTC Biospecifics Technologies... 10% Owner   –       –       •   2009-04-13 4 B $18.05 $5,126 I/I 284 824,944 1.5 -
BSTC Biospecifics Technologies... 10% Owner   –       –       •   2009-04-14 4 B $18.50 $16,650 I/I 900 825,844 1.5 -
DRNA Dicerna Pharmaceuticals I... Director   –       •      –    2019-11-25 4 S $24.06 $8,689,677 I/I (361,200) 883,576 0 -
EIDX Eidos Therapeutics, Inc. 10% Owner   –       –       •   2018-06-22 4 A $0.00 $0 I/I 1,103,847 1,103,847 0 -
RARX Ra Pharmaceuticals, Inc. 10% Owner   –       –       •   2016-10-31 4 A $0.00 $0 I/I 1,190,270 1,190,270 0 -
DRNA Dicerna Pharmaceuticals I... Director   –       •      –    2019-11-22 4 S $22.52 $4,451,492 I/I (197,700) 1,244,776 0 -
RARX Ra Pharmaceuticals, Inc. 10% Owner   –       –       •   2016-10-31 4 B $13.00 $2,099,994 I/I 161,538 1,351,808 1.5 -
KALV Kalvista Pharmaceuticals ... Director   –       •       •   2017-10-12 4 B $8.50 $7,225,000 I/I 850,000 1,441,070 2.25 -
KALA Kala Pharmaceuticals, Inc... former 10% owner   –       –      –    2017-07-25 4 A $0.00 $0 I/I 1,579,903 1,579,903 0 -
SGMO Sangamo Biosciences Inc Former 10% Owner   –       –      –    2014-08-01 4 S $12.82 $356,100 D/D (27,770) 1,829,426 0 -
  207  Records found
  1  2   3   4   5   6   7   8   9      
  Page 1 of 9  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us